Check out The Dose for the latest ARJ news and events.
Browse ARJ’s Media Archives to see additional coverage.
ARJ Begins Bamlanivimab Infusions for COVID-19 Patients
Jan. 7, 2021, Business Wire
ARJ Infusion Services will dispense and administer bamlanivimab (Eli Lilly), a monoclonal antibody drug to treat COVID-19. ARJ will dispense treatments to eligible high-risk individuals residing or working in assisted living and long-term care facilities.